

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 8.70784997 |
| 2 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 8.65590593 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 8.28365671 |
| 4 | regulation of fibrinolysis (GO:0051917) | 8.14030631 |
| 5 | regulation of T-helper 1 cell differentiation (GO:0045625) | 8.07108807 |
| 6 | regulation of protein activation cascade (GO:2000257) | 8.00869287 |
| 7 | complement activation, alternative pathway (GO:0006957) | 7.97793296 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 7.45458986 |
| 9 | regulation of complement activation (GO:0030449) | 7.38744085 |
| 10 | drug catabolic process (GO:0042737) | 6.92633722 |
| 11 | positive regulation of granulocyte chemotaxis (GO:0071624) | 6.80003851 |
| 12 | fibrinolysis (GO:0042730) | 6.73117143 |
| 13 | protein carboxylation (GO:0018214) | 6.60010074 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.60010074 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55806112 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 6.55806112 |
| 17 | cellular glucuronidation (GO:0052695) | 6.34998830 |
| 18 | negative regulation of sterol transport (GO:0032372) | 6.23300445 |
| 19 | negative regulation of cholesterol transport (GO:0032375) | 6.23300445 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 6.22218578 |
| 21 | regulation of antigen processing and presentation (GO:0002577) | 6.19646937 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.13799469 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 6.13220748 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.13220748 |
| 25 | myeloid dendritic cell differentiation (GO:0043011) | 6.10461098 |
| 26 | uronic acid metabolic process (GO:0006063) | 6.06679716 |
| 27 | glucuronate metabolic process (GO:0019585) | 6.06679716 |
| 28 | glycine metabolic process (GO:0006544) | 6.04411040 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 6.04283962 |
| 30 | tongue development (GO:0043586) | 5.98290724 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 5.95755517 |
| 32 | serine family amino acid biosynthetic process (GO:0009070) | 5.93029533 |
| 33 | peptide catabolic process (GO:0043171) | 5.86109694 |
| 34 | dendritic cell differentiation (GO:0097028) | 5.83093130 |
| 35 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.78064546 |
| 36 | exogenous drug catabolic process (GO:0042738) | 5.76841712 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 5.75104854 |
| 38 | negative regulation of interleukin-10 production (GO:0032693) | 5.74781338 |
| 39 | phospholipid efflux (GO:0033700) | 5.69884008 |
| 40 | phenylpropanoid metabolic process (GO:0009698) | 5.57749019 |
| 41 | oxidative demethylation (GO:0070989) | 5.54684127 |
| 42 | L-serine metabolic process (GO:0006563) | 5.52178633 |
| 43 | pericardium development (GO:0060039) | 5.52023151 |
| 44 | oxygen transport (GO:0015671) | 5.50935149 |
| 45 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 5.50107966 |
| 46 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.43780775 |
| 47 | regulation of plasminogen activation (GO:0010755) | 5.41316334 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 5.38888454 |
| 49 | positive regulation of neutrophil chemotaxis (GO:0090023) | 5.30651902 |
| 50 | positive regulation of neutrophil migration (GO:1902624) | 5.30651902 |
| 51 | serine family amino acid metabolic process (GO:0009069) | 5.29224839 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 5.20455837 |
| 53 | epoxygenase P450 pathway (GO:0019373) | 5.17269261 |
| 54 | response to nitric oxide (GO:0071731) | 5.12269389 |
| 55 | regulation of Cdc42 GTPase activity (GO:0043088) | 5.05079294 |
| 56 | hormone catabolic process (GO:0042447) | 5.04318862 |
| 57 | negative regulation of hemostasis (GO:1900047) | 5.03590455 |
| 58 | negative regulation of blood coagulation (GO:0030195) | 5.03590455 |
| 59 | bile acid biosynthetic process (GO:0006699) | 5.00906755 |
| 60 | myeloid dendritic cell activation (GO:0001773) | 4.97923329 |
| 61 | cysteine metabolic process (GO:0006534) | 4.90941053 |
| 62 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 4.86172471 |
| 63 | response to prostaglandin E (GO:0034695) | 4.84836454 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.83070909 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.83070909 |
| 66 | dendritic cell chemotaxis (GO:0002407) | 4.80242424 |
| 67 | protein activation cascade (GO:0072376) | 4.80196630 |
| 68 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.79854374 |
| 69 | superoxide anion generation (GO:0042554) | 4.79274496 |
| 70 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.72309974 |
| 71 | hydrogen peroxide catabolic process (GO:0042744) | 4.69683624 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.68558923 |
| 73 | omega-hydroxylase P450 pathway (GO:0097267) | 4.67905221 |
| 74 | bile acid metabolic process (GO:0008206) | 4.65963692 |
| 75 | heme transport (GO:0015886) | 4.64967331 |
| 76 | negative regulation of lipase activity (GO:0060192) | 4.64436853 |
| 77 | acute-phase response (GO:0006953) | 4.62883255 |
| 78 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.61137709 |
| 79 | neurotransmitter catabolic process (GO:0042135) | 4.59148619 |
| 80 | biotin metabolic process (GO:0006768) | 4.58209057 |
| 81 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.57521717 |
| 82 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.56993351 |
| 83 | negative regulation of coagulation (GO:0050819) | 4.56179391 |
| 84 | drug metabolic process (GO:0017144) | 4.53480335 |
| 85 | high-density lipoprotein particle remodeling (GO:0034375) | 4.51070812 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 4.50291814 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 4.50291814 |
| 88 | macromolecular complex remodeling (GO:0034367) | 4.50291814 |
| 89 | ventricular cardiac muscle cell development (GO:0055015) | 4.49119688 |
| 90 | complement activation (GO:0006956) | 4.48066845 |
| 91 | regulation of humoral immune response (GO:0002920) | 4.47081744 |
| 92 | renal absorption (GO:0070293) | 4.42543439 |
| 93 | aromatic amino acid family catabolic process (GO:0009074) | 4.39914541 |
| 94 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.39475908 |
| 95 | bile acid and bile salt transport (GO:0015721) | 4.39021183 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.38740234 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.38740234 |
| 98 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.37161017 |
| 99 | negative regulation of complement activation (GO:0045916) | 4.34565261 |
| 100 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 4.31831003 |
| 101 | leukotriene biosynthetic process (GO:0019370) | 4.26685117 |
| 102 | regulation of granulocyte chemotaxis (GO:0071622) | 4.26144008 |
| 103 | sulfur amino acid catabolic process (GO:0000098) | 4.20359315 |
| 104 | daunorubicin metabolic process (GO:0044597) | 4.19571382 |
| 105 | polyketide metabolic process (GO:0030638) | 4.19571382 |
| 106 | doxorubicin metabolic process (GO:0044598) | 4.19571382 |
| 107 | complement activation, classical pathway (GO:0006958) | 4.19306954 |
| 108 | positive regulation of hemostasis (GO:1900048) | 4.18865163 |
| 109 | positive regulation of blood coagulation (GO:0030194) | 4.18865163 |
| 110 | * regulation of lipoprotein particle clearance (GO:0010984) | 4.13673056 |
| 111 | regulation of T-helper 1 type immune response (GO:0002825) | 4.03855733 |
| 112 | regulation of interleukin-1 secretion (GO:0050704) | 3.98112183 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 3.95864796 |
| 114 | positive regulation of interleukin-1 production (GO:0032732) | 3.92956168 |
| 115 | amino-acid betaine metabolic process (GO:0006577) | 3.92574041 |
| 116 | nitric oxide biosynthetic process (GO:0006809) | 3.88784380 |
| 117 | steroid catabolic process (GO:0006706) | 3.88231680 |
| 118 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.86389929 |
| 119 | cholesterol efflux (GO:0033344) | 3.85898228 |
| 120 | regulation of neutrophil migration (GO:1902622) | 3.85866360 |
| 121 | regulation of neutrophil chemotaxis (GO:0090022) | 3.85866360 |
| 122 | pharyngeal system development (GO:0060037) | 3.84385295 |
| 123 | positive regulation of coagulation (GO:0050820) | 3.84337639 |
| 124 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.82896293 |
| 125 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.82025065 |
| 126 | synaptic transmission, cholinergic (GO:0007271) | 3.77936352 |
| 127 | acute inflammatory response (GO:0002526) | 3.76946930 |
| 128 | amine biosynthetic process (GO:0009309) | 3.76099749 |
| 129 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.76099749 |
| 130 | response to prostaglandin (GO:0034694) | 3.75813185 |
| 131 | reverse cholesterol transport (GO:0043691) | 3.74485971 |
| 132 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.71812665 |
| 133 | regulation of T-helper cell differentiation (GO:0045622) | 3.71609626 |
| 134 | arginine metabolic process (GO:0006525) | 3.70160839 |
| 135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.70033398 |
| 136 | cellular response to ATP (GO:0071318) | 3.69958982 |
| 137 | embryonic digestive tract development (GO:0048566) | 3.66150565 |
| 138 | ethanol oxidation (GO:0006069) | 3.65464226 |
| 139 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.64989104 |
| 140 | proline metabolic process (GO:0006560) | 3.64718550 |
| 141 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.62574458 |
| 142 | positive regulation of growth hormone secretion (GO:0060124) | 3.61193235 |
| 143 | S-adenosylmethionine metabolic process (GO:0046500) | 3.58274149 |
| 144 | lung vasculature development (GO:0060426) | 3.57421673 |
| 145 | plasma lipoprotein particle assembly (GO:0034377) | 3.57180562 |
| 146 | eosinophil migration (GO:0072677) | 3.57014889 |
| 147 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.56957275 |
| 148 | urea metabolic process (GO:0019627) | 3.55509489 |
| 149 | urea cycle (GO:0000050) | 3.55509489 |
| 150 | alpha-amino acid catabolic process (GO:1901606) | 3.49135103 |
| 151 | hypothalamus development (GO:0021854) | 3.48932052 |
| 152 | primary alcohol catabolic process (GO:0034310) | 3.48572019 |
| 153 | embryonic heart tube development (GO:0035050) | 3.47974929 |
| 154 | drug transmembrane transport (GO:0006855) | 3.47095414 |
| 155 | cytolysis (GO:0019835) | 3.46873949 |
| 156 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.41527554 |
| 157 | leukotriene metabolic process (GO:0006691) | 3.41378335 |
| 158 | positive regulation of lipid catabolic process (GO:0050996) | 3.41012515 |
| 159 | aldehyde catabolic process (GO:0046185) | 3.40220909 |
| 160 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.39403153 |
| 161 | growth hormone secretion (GO:0030252) | 3.38448812 |
| 162 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.36123782 |
| 163 | positive regulation of response to tumor cell (GO:0002836) | 3.35772920 |
| 164 | hydrogen peroxide metabolic process (GO:0042743) | 3.33064033 |
| 165 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.28859502 |
| 166 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.28434793 |
| 167 | glutathione biosynthetic process (GO:0006750) | 3.28166897 |
| 168 | regulation of phospholipase A2 activity (GO:0032429) | 3.25885724 |
| 169 | dendritic cell migration (GO:0036336) | 3.25334646 |
| 170 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.20949053 |
| 171 | striated muscle atrophy (GO:0014891) | 3.20554692 |
| 172 | nitrogen cycle metabolic process (GO:0071941) | 3.18091581 |
| 173 | regulation of activation of Janus kinase activity (GO:0010533) | 3.12671720 |
| 174 | diaphragm development (GO:0060539) | 3.12664955 |
| 175 | head development (GO:0060322) | 3.06048795 |
| 176 | positive regulation of interleukin-12 production (GO:0032735) | 3.04815532 |
| 177 | lung epithelium development (GO:0060428) | 3.04750950 |
| 178 | alkaloid metabolic process (GO:0009820) | 3.01123108 |
| 179 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.97630214 |
| 180 | positive regulation of interleukin-4 production (GO:0032753) | 2.96161890 |
| 181 | vitamin transmembrane transport (GO:0035461) | 2.96085465 |
| 182 | regulation of RIG-I signaling pathway (GO:0039535) | 2.95704154 |
| 183 | activation of Rac GTPase activity (GO:0032863) | 2.94004223 |
| 184 | fucose catabolic process (GO:0019317) | 2.91643374 |
| 185 | L-fucose metabolic process (GO:0042354) | 2.91643374 |
| 186 | L-fucose catabolic process (GO:0042355) | 2.91643374 |
| 187 | gas transport (GO:0015669) | 2.91361794 |
| 188 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89506682 |
| 189 | protein retention in ER lumen (GO:0006621) | 2.86822219 |
| 190 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.82776794 |
| 191 | skeletal muscle organ development (GO:0060538) | 2.82089159 |
| 192 | intestinal cholesterol absorption (GO:0030299) | 2.81965374 |
| 193 | auditory behavior (GO:0031223) | 2.79863515 |
| 194 | programmed necrotic cell death (GO:0097300) | 2.77556905 |
| 195 | imidazole-containing compound metabolic process (GO:0052803) | 11.0963648 |
| 196 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 10.9940244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.93486420 |
| 2 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.60851738 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.18347335 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.06049578 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.05351464 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.82579784 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.77528190 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41318053 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38772309 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.22825903 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15160024 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.03843822 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02484702 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96583781 |
| 15 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.96452512 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96081247 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95949291 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95640623 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.95473744 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92328861 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83109187 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80153524 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73836493 |
| 24 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73169211 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71309821 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68036265 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64614510 |
| 28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61791770 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59683225 |
| 30 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.58540043 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57711296 |
| 32 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.57372145 |
| 33 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.57372145 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57244876 |
| 35 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.56592640 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54836129 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54090599 |
| 38 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.53231701 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.52022118 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48889441 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48101372 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46778808 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46724739 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46134401 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45814844 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.42121587 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40211395 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38320506 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.36379843 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.36379843 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36133419 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36109349 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35023063 |
| 54 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.33249595 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32423166 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30986567 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29338671 |
| 58 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28626803 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26676054 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25341849 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24916955 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24848636 |
| 63 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.24552563 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23380483 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23317504 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.23137375 |
| 67 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23029222 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.18187221 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17554356 |
| 70 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.15840895 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.15712981 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14554400 |
| 73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14107475 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.12056599 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11457806 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09712234 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09624653 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09558029 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09330790 |
| 80 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.08980250 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08875742 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06518952 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06494449 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05348201 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04993785 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02316286 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98781190 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98023385 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97858099 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97409045 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.96989049 |
| 92 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96767799 |
| 93 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96753792 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95864875 |
| 95 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95295544 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95203087 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94382902 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93584264 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90862307 |
| 100 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90038815 |
| 101 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89921930 |
| 102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89596185 |
| 103 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88552237 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87691280 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87147778 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.86487798 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85761461 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85521730 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.84414772 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.84077058 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83666838 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83534423 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83362150 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.82946744 |
| 115 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82710570 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82576310 |
| 117 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82209826 |
| 118 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.82043377 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82042515 |
| 120 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81823290 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81659562 |
| 122 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80746634 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80465976 |
| 124 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80458497 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80457487 |
| 126 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.80087408 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79643047 |
| 128 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79385171 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78331699 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78103010 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77841765 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77379300 |
| 133 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77265418 |
| 134 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.77238775 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77209061 |
| 136 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.75631586 |
| 137 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.75583964 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75275411 |
| 139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.75009113 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74571042 |
| 141 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.74397603 |
| 142 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74377167 |
| 143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74026726 |
| 144 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73936641 |
| 145 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.73032636 |
| 146 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.72913833 |
| 147 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.72566494 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72496632 |
| 149 | NFYA_21822215_ChIP-Seq_K562_Human | 0.72477301 |
| 150 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.69302582 |
| 151 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69140085 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.69125133 |
| 153 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68105414 |
| 154 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.67917900 |
| 155 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.67806604 |
| 156 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.64535747 |
| 157 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.64191962 |
| 158 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62572393 |
| 159 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.62233496 |
| 160 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.62221396 |
| 161 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60496825 |
| 162 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.60217345 |
| 163 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.59518391 |
| 164 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59403436 |
| 165 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59274276 |
| 166 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.58820419 |
| 167 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.57653081 |
| 168 | NFYB_21822215_ChIP-Seq_K562_Human | 0.57413531 |
| 169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.56461444 |
| 170 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.56457199 |
| 171 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.56146722 |
| 172 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.55159283 |
| 173 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.54798891 |
| 174 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54135358 |
| 175 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.54022849 |
| 176 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.53589403 |
| 177 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.53566788 |
| 178 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53172511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 8.58105996 |
| 2 | MP0002876_abnormal_thyroid_physiology | 8.05848701 |
| 3 | MP0000685_abnormal_immune_system | 5.44224721 |
| 4 | MP0001348_abnormal_lacrimal_gland | 4.58175750 |
| 5 | MP0001346_abnormal_lacrimal_gland | 4.34234861 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.22131455 |
| 7 | MP0004510_myositis | 3.89769129 |
| 8 | MP0003252_abnormal_bile_duct | 3.71866730 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.65418033 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 3.60590443 |
| 11 | MP0009697_abnormal_copulation | 3.39451815 |
| 12 | MP0003879_abnormal_hair_cell | 3.18152656 |
| 13 | MP0005310_abnormal_salivary_gland | 3.04417342 |
| 14 | MP0009840_abnormal_foam_cell | 3.03393935 |
| 15 | MP0001873_stomach_inflammation | 2.76598511 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.37328861 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.26087187 |
| 18 | MP0006082_CNS_inflammation | 2.12117202 |
| 19 | MP0005671_abnormal_response_to | 2.06003317 |
| 20 | MP0000566_synostosis | 1.89243899 |
| 21 | MP0005083_abnormal_biliary_tract | 1.88625176 |
| 22 | MP0003868_abnormal_feces_composition | 1.87731247 |
| 23 | * MP0001764_abnormal_homeostasis | 1.85575593 |
| 24 | MP0005647_abnormal_sex_gland | 1.80885777 |
| 25 | * MP0000609_abnormal_liver_physiology | 1.79541518 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.63267496 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.59593196 |
| 28 | MP0003638_abnormal_response/metabolism_ | 1.55667248 |
| 29 | MP0005408_hypopigmentation | 1.54612402 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.48475296 |
| 31 | MP0005365_abnormal_bile_salt | 1.47970730 |
| 32 | MP0001661_extended_life_span | 1.47491876 |
| 33 | MP0003186_abnormal_redox_activity | 1.44774073 |
| 34 | MP0001853_heart_inflammation | 1.44106472 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.37547700 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.34515516 |
| 37 | MP0000470_abnormal_stomach_morphology | 1.28588559 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.26340272 |
| 39 | MP0009053_abnormal_anal_canal | 1.23449641 |
| 40 | * MP0003959_abnormal_lean_body | 1.14994021 |
| 41 | MP0000613_abnormal_salivary_gland | 1.14850855 |
| 42 | MP0003011_delayed_dark_adaptation | 1.12467720 |
| 43 | MP0001542_abnormal_bone_strength | 1.08979191 |
| 44 | MP0005187_abnormal_penis_morphology | 1.08534589 |
| 45 | * MP0000598_abnormal_liver_morphology | 1.04968489 |
| 46 | MP0005387_immune_system_phenotype | 1.02622128 |
| 47 | MP0001790_abnormal_immune_system | 1.02622128 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.00295367 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 0.99468238 |
| 50 | MP0002693_abnormal_pancreas_physiology | 0.98801013 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 0.98102914 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96636656 |
| 53 | MP0009765_abnormal_xenobiotic_induced | 0.94432548 |
| 54 | MP0002160_abnormal_reproductive_system | 0.93644601 |
| 55 | MP0000604_amyloidosis | 0.93406228 |
| 56 | MP0009764_decreased_sensitivity_to | 0.91716854 |
| 57 | MP0005025_abnormal_response_to | 0.90963893 |
| 58 | MP0005332_abnormal_amino_acid | 0.90290690 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 0.89569032 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 0.88555043 |
| 61 | MP0010386_abnormal_urinary_bladder | 0.88038761 |
| 62 | MP0002734_abnormal_mechanical_nocicepti | 0.86734370 |
| 63 | MP0001299_abnormal_eye_distance/ | 0.85665823 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 0.84795790 |
| 65 | MP0001915_intracranial_hemorrhage | 0.84647042 |
| 66 | MP0004134_abnormal_chest_morphology | 0.83825483 |
| 67 | MP0005448_abnormal_energy_balance | 0.83496889 |
| 68 | * MP0009642_abnormal_blood_homeostasis | 0.83257428 |
| 69 | MP0000579_abnormal_nail_morphology | 0.82636110 |
| 70 | MP0005395_other_phenotype | 0.82110114 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.81866737 |
| 72 | MP0000681_abnormal_thyroid_gland | 0.80707766 |
| 73 | MP0001881_abnormal_mammary_gland | 0.80125017 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.79121013 |
| 75 | MP0002405_respiratory_system_inflammati | 0.79052161 |
| 76 | * MP0005376_homeostasis/metabolism_phenot | 0.78673613 |
| 77 | MP0008872_abnormal_physiological_respon | 0.78589072 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.77824975 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.77369631 |
| 80 | MP0000383_abnormal_hair_follicle | 0.77180883 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.76945097 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.76160332 |
| 83 | MP0004270_analgesia | 0.75896975 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 0.75253513 |
| 85 | MP0002009_preneoplasia | 0.74402802 |
| 86 | MP0001800_abnormal_humoral_immune | 0.74241135 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.74007600 |
| 88 | MP0002733_abnormal_thermal_nociception | 0.73233342 |
| 89 | * MP0005645_abnormal_hypothalamus_physiol | 0.72886747 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 0.69466693 |
| 91 | MP0001243_abnormal_dermal_layer | 0.68954919 |
| 92 | MP0009785_altered_susceptibility_to | 0.68504185 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.67370340 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.66352453 |
| 95 | MP0002928_abnormal_bile_duct | 0.63766516 |
| 96 | MP0000427_abnormal_hair_cycle | 0.63503921 |
| 97 | MP0001851_eye_inflammation | 0.62640924 |
| 98 | MP0003195_calcinosis | 0.62576011 |
| 99 | MP0009763_increased_sensitivity_to | 0.61325743 |
| 100 | MP0003718_maternal_effect | 0.60745267 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.60199007 |
| 102 | MP0010678_abnormal_skin_adnexa | 0.59668326 |
| 103 | MP0005360_urolithiasis | 0.57522402 |
| 104 | MP0004233_abnormal_muscle_weight | 0.57007499 |
| 105 | MP0008469_abnormal_protein_level | 0.56140602 |
| 106 | MP0008569_lethality_at_weaning | 0.55701277 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.55536605 |
| 108 | MP0004272_abnormal_basement_membrane | 0.55193670 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.54607633 |
| 110 | MP0000733_abnormal_muscle_development | 0.54113805 |
| 111 | MP0001663_abnormal_digestive_system | 0.52412564 |
| 112 | * MP0002971_abnormal_brown_adipose | 0.50334807 |
| 113 | MP0002419_abnormal_innate_immunity | 0.49557093 |
| 114 | MP0008789_abnormal_olfactory_epithelium | 0.49022177 |
| 115 | MP0001756_abnormal_urination | 0.48914240 |
| 116 | MP0005451_abnormal_body_composition | 0.48177964 |
| 117 | MP0005670_abnormal_white_adipose | 0.47500770 |
| 118 | MP0002697_abnormal_eye_size | 0.46079503 |
| 119 | MP0001970_abnormal_pain_threshold | 0.45433593 |
| 120 | MP0006035_abnormal_mitochondrial_morpho | 0.44549950 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.44519417 |
| 122 | MP0009672_abnormal_birth_weight | 0.44449291 |
| 123 | MP0002452_abnormal_antigen_presenting | 0.44413139 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.44380163 |
| 125 | * MP0002078_abnormal_glucose_homeostasis | 0.43768109 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.43037220 |
| 127 | MP0002249_abnormal_larynx_morphology | 0.42547357 |
| 128 | * MP0002118_abnormal_lipid_homeostasis | 0.41629322 |
| 129 | MP0006138_congestive_heart_failure | 0.41580217 |
| 130 | MP0005058_abnormal_lysosome_morphology | 0.41339816 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.41326330 |
| 132 | MP0005197_abnormal_uvea_morphology | 0.41269626 |
| 133 | MP0002269_muscular_atrophy | 0.41171663 |
| 134 | MP0002723_abnormal_immune_serum | 0.41011521 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.40121606 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.39771869 |
| 137 | MP0002168_other_aberrant_phenotype | 0.39576756 |
| 138 | MP0002796_impaired_skin_barrier | 0.39479476 |
| 139 | MP0001819_abnormal_immune_cell | 0.38653009 |
| 140 | MP0002420_abnormal_adaptive_immunity | 0.38274922 |
| 141 | MP0005535_abnormal_body_temperature | 0.37969089 |
| 142 | MP0008873_increased_physiological_sensi | 0.37893037 |
| 143 | MP0005164_abnormal_response_to | 0.37734661 |
| 144 | MP0000467_abnormal_esophagus_morphology | 0.37638112 |
| 145 | MP0002132_abnormal_respiratory_system | 0.36624561 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.35713219 |
| 147 | MP0005410_abnormal_fertilization | 0.35524038 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.35292466 |
| 149 | MP0005266_abnormal_metabolism | 0.35069996 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.34337017 |
| 151 | MP0003941_abnormal_skin_development | 0.33826927 |
| 152 | MP0003690_abnormal_glial_cell | 0.33693709 |
| 153 | MP0005464_abnormal_platelet_physiology | 0.33517113 |
| 154 | MP0002282_abnormal_trachea_morphology | 0.33118278 |
| 155 | MP0003656_abnormal_erythrocyte_physiolo | 0.32891651 |
| 156 | MP0003699_abnormal_female_reproductive | 0.31406984 |
| 157 | MP0005377_hearing/vestibular/ear_phenot | 0.31151827 |
| 158 | MP0003878_abnormal_ear_physiology | 0.31151827 |
| 159 | MP0003693_abnormal_embryo_hatching | 0.31148076 |
| 160 | MP0005023_abnormal_wound_healing | 0.29197192 |
| 161 | MP0000367_abnormal_coat/_hair | 0.27420644 |
| 162 | MP0001944_abnormal_pancreas_morphology | 0.27189343 |
| 163 | * MP0002970_abnormal_white_adipose | 0.26617133 |
| 164 | * MP0003953_abnormal_hormone_level | 0.25650042 |
| 165 | MP0000249_abnormal_blood_vessel | 0.24345618 |
| 166 | * MP0005334_abnormal_fat_pad | 0.24097260 |
| 167 | MP0002090_abnormal_vision | 0.22945196 |
| 168 | MP0002161_abnormal_fertility/fecundity | 0.22279688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.91012482 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.67140773 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 8.07020648 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.69531562 |
| 5 | Complement deficiency (HP:0004431) | 7.63916881 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.86556223 |
| 7 | Congenital malformation of the right heart (HP:0011723) | 6.79298160 |
| 8 | Double outlet right ventricle (HP:0001719) | 6.79298160 |
| 9 | Abnormality of complement system (HP:0005339) | 6.09935200 |
| 10 | Type I diabetes mellitus (HP:0100651) | 5.93617052 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.71348667 |
| 12 | Glomerulonephritis (HP:0000099) | 5.62349108 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 5.51313335 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.51313335 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 5.48719059 |
| 16 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 5.48195844 |
| 17 | Joint hemorrhage (HP:0005261) | 5.40062285 |
| 18 | Type 2 muscle fiber atrophy (HP:0003554) | 5.34512403 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 5.13961329 |
| 20 | Upper limb muscle weakness (HP:0003484) | 4.86294712 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.72926244 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 4.72428134 |
| 23 | Truncus arteriosus (HP:0001660) | 4.62585568 |
| 24 | Muscle fiber atrophy (HP:0100295) | 4.59890948 |
| 25 | Xanthomatosis (HP:0000991) | 4.41440869 |
| 26 | Spontaneous abortion (HP:0005268) | 4.41401525 |
| 27 | Abnormal pupillary function (HP:0007686) | 4.36615535 |
| 28 | Hypolipoproteinemia (HP:0010981) | 4.29983558 |
| 29 | Keratoconjunctivitis (HP:0001096) | 4.22639933 |
| 30 | Abnormality of placental membranes (HP:0011409) | 4.21646497 |
| 31 | Amniotic constriction ring (HP:0009775) | 4.21646497 |
| 32 | Abnormality of the neuromuscular junction (HP:0003398) | 4.20053652 |
| 33 | Fatigable weakness (HP:0003473) | 4.20053652 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 3.87168113 |
| 35 | Tongue fasciculations (HP:0001308) | 3.85738877 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 3.80371659 |
| 37 | Muscle fibrillation (HP:0010546) | 3.78853209 |
| 38 | Weak cry (HP:0001612) | 3.74918682 |
| 39 | Eczematoid dermatitis (HP:0000976) | 3.73329998 |
| 40 | Hyperglycinemia (HP:0002154) | 3.70042519 |
| 41 | Hydroxyprolinuria (HP:0003080) | 3.66226904 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 3.66226904 |
| 43 | Asplenia (HP:0001746) | 3.53123794 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.49978485 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.48525844 |
| 46 | Nephritis (HP:0000123) | 3.47726779 |
| 47 | Recurrent skin infections (HP:0001581) | 3.47475308 |
| 48 | Abnormal auditory evoked potentials (HP:0006958) | 3.47317985 |
| 49 | Lip pit (HP:0100267) | 3.45258587 |
| 50 | Hyperammonemia (HP:0001987) | 3.44889115 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 3.36824833 |
| 52 | Cholecystitis (HP:0001082) | 3.36824833 |
| 53 | Transposition of the great arteries (HP:0001669) | 3.33426358 |
| 54 | Abnormal connection of the cardiac segments (HP:0011545) | 3.33426358 |
| 55 | Abnormal ventriculo-arterial connection (HP:0011563) | 3.33426358 |
| 56 | Abnormality of the gastric mucosa (HP:0004295) | 3.24680127 |
| 57 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.23963799 |
| 58 | Hyperglycemia (HP:0003074) | 3.21785090 |
| 59 | Confusion (HP:0001289) | 3.14429687 |
| 60 | Hypercortisolism (HP:0001578) | 3.12294106 |
| 61 | Annular pancreas (HP:0001734) | 3.11482306 |
| 62 | Generalized aminoaciduria (HP:0002909) | 3.10894087 |
| 63 | Recurrent fungal infections (HP:0002841) | 3.07818164 |
| 64 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.07250616 |
| 65 | Hyperglycinuria (HP:0003108) | 3.02709027 |
| 66 | Xerostomia (HP:0000217) | 3.00187704 |
| 67 | Abnormal pancreas size (HP:0012094) | 2.99628230 |
| 68 | Abnormality of the aortic arch (HP:0012303) | 2.96761193 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89876298 |
| 70 | Hypoplasia of the uterus (HP:0000013) | 2.89306828 |
| 71 | Bilateral microphthalmos (HP:0007633) | 2.78904687 |
| 72 | Reticulocytosis (HP:0001923) | 2.78792732 |
| 73 | Easy fatigability (HP:0003388) | 2.75376891 |
| 74 | Popliteal pterygium (HP:0009756) | 2.73391494 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.69003110 |
| 76 | Increased IgE level (HP:0003212) | 2.68769742 |
| 77 | Cholelithiasis (HP:0001081) | 2.67636598 |
| 78 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.66988762 |
| 79 | Gingival bleeding (HP:0000225) | 2.66357945 |
| 80 | Rickets (HP:0002748) | 2.60804995 |
| 81 | Hypoalphalipoproteinemia (HP:0003233) | 2.60418719 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.57272898 |
| 83 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56433371 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.54619942 |
| 85 | Increased serum pyruvate (HP:0003542) | 2.52240939 |
| 86 | Ketoacidosis (HP:0001993) | 2.52133975 |
| 87 | Steatorrhea (HP:0002570) | 2.49178947 |
| 88 | Osteomalacia (HP:0002749) | 2.47107034 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46914085 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.44820102 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.44408951 |
| 92 | Hypoplasia of dental enamel (HP:0006297) | 2.42891954 |
| 93 | Down-sloping shoulders (HP:0200021) | 2.41090505 |
| 94 | Delayed CNS myelination (HP:0002188) | 2.40825044 |
| 95 | Recurrent bacterial skin infections (HP:0005406) | 2.39753591 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 2.39028064 |
| 97 | Hypercholesterolemia (HP:0003124) | 2.34425786 |
| 98 | Fetal akinesia sequence (HP:0001989) | 2.32722156 |
| 99 | Abnormal hand bone ossification (HP:0010660) | 2.31089547 |
| 100 | Thrombophlebitis (HP:0004418) | 2.30888957 |
| 101 | Plantar hyperkeratosis (HP:0007556) | 2.28679065 |
| 102 | Polycythemia (HP:0001901) | 2.28448064 |
| 103 | Abnormality of glycolysis (HP:0004366) | 2.28365761 |
| 104 | Menorrhagia (HP:0000132) | 2.26730999 |
| 105 | Purpura (HP:0000979) | 2.26422065 |
| 106 | Cerebral edema (HP:0002181) | 2.26204857 |
| 107 | Pterygium (HP:0001059) | 2.25144006 |
| 108 | Abnormal ossification of hand bones (HP:0005921) | 2.24064499 |
| 109 | Neoplasm of the heart (HP:0100544) | 2.23852208 |
| 110 | Aplasia of the musculature (HP:0100854) | 2.23639861 |
| 111 | Akinesia (HP:0002304) | 2.20874791 |
| 112 | Abnormality of the parietal bone (HP:0002696) | 2.19117220 |
| 113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.18020833 |
| 114 | Deformed sella turcica (HP:0002681) | 2.17299879 |
| 115 | Recurrent pneumonia (HP:0006532) | 2.17202776 |
| 116 | Hyperbilirubinemia (HP:0002904) | 2.12956303 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12686628 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 2.12000413 |
| 119 | Hyperalaninemia (HP:0003348) | 2.12000413 |
| 120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.12000413 |
| 121 | Malignant hyperthermia (HP:0002047) | 2.11464896 |
| 122 | Poikilocytosis (HP:0004447) | 2.11182063 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09848233 |
| 124 | Increased serum ferritin (HP:0003281) | 2.09552618 |
| 125 | Trismus (HP:0000211) | 2.09439305 |
| 126 | Bifid scrotum (HP:0000048) | 2.07562367 |
| 127 | Hyperphosphaturia (HP:0003109) | 2.07295901 |
| 128 | Palmoplantar hyperkeratosis (HP:0000972) | 2.07227160 |
| 129 | Paraparesis (HP:0002385) | 2.07011211 |
| 130 | Abnormality of urine glucose concentration (HP:0011016) | 2.06897401 |
| 131 | Glycosuria (HP:0003076) | 2.06897401 |
| 132 | Metabolic acidosis (HP:0001942) | 2.06764689 |
| 133 | Decreased muscle mass (HP:0003199) | 2.06385982 |
| 134 | Abnormality of glycine metabolism (HP:0010895) | 2.05876820 |
| 135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05876820 |
| 136 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.00039282 |
| 137 | Squamous cell carcinoma (HP:0002860) | 1.99685391 |
| 138 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.98655052 |
| 139 | Urticaria (HP:0001025) | 1.98256874 |
| 140 | Onycholysis (HP:0001806) | 1.97327685 |
| 141 | Keratitis (HP:0000491) | 1.96357340 |
| 142 | Respiratory distress (HP:0002098) | 1.96267227 |
| 143 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95404457 |
| 144 | Pulmonary embolism (HP:0002204) | 1.95015219 |
| 145 | Bile duct proliferation (HP:0001408) | 1.93832878 |
| 146 | Abnormal biliary tract physiology (HP:0012439) | 1.93832878 |
| 147 | Hepatitis (HP:0012115) | 1.92813463 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.92123950 |
| 149 | Alkalosis (HP:0001948) | 1.91873747 |
| 150 | Pustule (HP:0200039) | 1.91616946 |
| 151 | Abnormality of iron homeostasis (HP:0011031) | 1.89719063 |
| 152 | Fair hair (HP:0002286) | 1.89194673 |
| 153 | Absent phalangeal crease (HP:0006109) | 1.88856636 |
| 154 | Palmar hyperkeratosis (HP:0010765) | 1.88813785 |
| 155 | Elevated alkaline phosphatase (HP:0003155) | 1.88710482 |
| 156 | Irritability (HP:0000737) | 1.88270954 |
| 157 | Mitral stenosis (HP:0001718) | 1.88136946 |
| 158 | Amelogenesis imperfecta (HP:0000705) | 1.86132054 |
| 159 | Myositis (HP:0100614) | 1.85233357 |
| 160 | Lethargy (HP:0001254) | 1.84623183 |
| 161 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84499568 |
| 162 | Abnormality of vitamin metabolism (HP:0100508) | 1.84453654 |
| 163 | Milia (HP:0001056) | 1.83411025 |
| 164 | Progressive muscle weakness (HP:0003323) | 1.83006420 |
| 165 | Poor suck (HP:0002033) | 1.82756669 |
| 166 | Ketosis (HP:0001946) | 1.82120830 |
| 167 | Fat malabsorption (HP:0002630) | 1.81894091 |
| 168 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81546560 |
| 169 | Vascular calcification (HP:0004934) | 1.80768507 |
| 170 | Agammaglobulinemia (HP:0004432) | 1.80649824 |
| 171 | Anophthalmia (HP:0000528) | 1.80491181 |
| 172 | Intrahepatic cholestasis (HP:0001406) | 1.79646925 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.79290175 |
| 174 | Atrioventricular block (HP:0001678) | 1.78671633 |
| 175 | Abnormal delivery (HP:0001787) | 1.77711405 |
| 176 | Gastrointestinal stroma tumor (HP:0100723) | 1.77707969 |
| 177 | Short 4th metacarpal (HP:0010044) | 1.77398437 |
| 178 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.77398437 |
| 179 | Abnormality of the gallbladder (HP:0005264) | 1.77183011 |
| 180 | Hypoproteinemia (HP:0003075) | 1.76587130 |
| 181 | Reduced antithrombin III activity (HP:0001976) | 1.76122632 |
| 182 | Arthropathy (HP:0003040) | 1.74349336 |
| 183 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73363500 |
| 184 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72867168 |
| 185 | Epidermoid cyst (HP:0200040) | 1.72312251 |
| 186 | Abnormal urine phosphate concentration (HP:0012599) | 1.72184232 |
| 187 | Lower limb hyperreflexia (HP:0002395) | 1.71354445 |
| 188 | Gangrene (HP:0100758) | 1.69622838 |
| 189 | Spastic paraparesis (HP:0002313) | 1.69011215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.86993373 |
| 2 | DYRK1B | 5.25071159 |
| 3 | IRAK4 | 4.06296978 |
| 4 | MST1R | 3.32285358 |
| 5 | IRAK3 | 3.29335784 |
| 6 | BMPR2 | 3.22316991 |
| 7 | LATS2 | 2.81016002 |
| 8 | PDK2 | 2.66716138 |
| 9 | STK38L | 2.65915133 |
| 10 | SRPK1 | 2.59688877 |
| 11 | ERBB3 | 2.55530716 |
| 12 | PTK6 | 2.52042362 |
| 13 | EIF2AK1 | 2.44829112 |
| 14 | EPHA3 | 2.43877922 |
| 15 | MST4 | 2.28453039 |
| 16 | RIPK1 | 2.28192738 |
| 17 | NEK1 | 2.27510971 |
| 18 | ZAK | 2.25794283 |
| 19 | NLK | 2.25789123 |
| 20 | NME1 | 2.20589409 |
| 21 | BCKDK | 2.16677439 |
| 22 | TBK1 | 2.16056233 |
| 23 | TTK | 2.08432353 |
| 24 | ERN1 | 1.97663980 |
| 25 | PBK | 1.95686562 |
| 26 | PIK3CG | 1.94966180 |
| 27 | FGFR4 | 1.94152887 |
| 28 | BCR | 1.90268679 |
| 29 | PIM2 | 1.85863155 |
| 30 | CDC7 | 1.80818451 |
| 31 | JAK3 | 1.72135280 |
| 32 | VRK2 | 1.72099613 |
| 33 | ITK | 1.70512952 |
| 34 | MUSK | 1.53427388 |
| 35 | IKBKE | 1.53047938 |
| 36 | EPHB1 | 1.51977196 |
| 37 | TYK2 | 1.48979681 |
| 38 | PRKCI | 1.48802423 |
| 39 | DYRK3 | 1.48671111 |
| 40 | MAP3K3 | 1.43559367 |
| 41 | ICK | 1.41560126 |
| 42 | CHUK | 1.40249526 |
| 43 | NUAK1 | 1.39710482 |
| 44 | PRKACG | 1.35572483 |
| 45 | PRKCG | 1.34790370 |
| 46 | EPHA2 | 1.28765436 |
| 47 | MAP2K2 | 1.28036360 |
| 48 | PLK4 | 1.26575291 |
| 49 | IKBKB | 1.25740311 |
| 50 | NEK9 | 1.25073748 |
| 51 | ABL2 | 1.24037012 |
| 52 | STK16 | 1.23700121 |
| 53 | SCYL2 | 1.22210225 |
| 54 | NTRK1 | 1.16234201 |
| 55 | MELK | 1.15468246 |
| 56 | AKT3 | 1.14331099 |
| 57 | CDC42BPA | 1.13311003 |
| 58 | JAK2 | 1.11170780 |
| 59 | TEC | 1.10494213 |
| 60 | IRAK1 | 1.06204552 |
| 61 | PRKAA2 | 1.06083075 |
| 62 | PTK2 | 1.04407031 |
| 63 | CAMK1D | 1.01178738 |
| 64 | CDK6 | 1.00864208 |
| 65 | BTK | 1.00712290 |
| 66 | TLK1 | 1.00492814 |
| 67 | NEK2 | 0.99907156 |
| 68 | BRSK2 | 0.99361097 |
| 69 | TRIB3 | 0.97250430 |
| 70 | PKN1 | 0.96453221 |
| 71 | MOS | 0.96136068 |
| 72 | NME2 | 0.95323926 |
| 73 | MAP3K13 | 0.93207952 |
| 74 | PDPK1 | 0.93192864 |
| 75 | CDK4 | 0.93071089 |
| 76 | CHEK2 | 0.89258123 |
| 77 | PRKCQ | 0.88913845 |
| 78 | SYK | 0.88717581 |
| 79 | FGFR3 | 0.84313506 |
| 80 | MAPKAPK5 | 0.83293385 |
| 81 | CDK7 | 0.83136501 |
| 82 | FLT3 | 0.82839208 |
| 83 | JAK1 | 0.82062833 |
| 84 | CSNK2A1 | 0.79306856 |
| 85 | PAK4 | 0.78187911 |
| 86 | LMTK2 | 0.77788621 |
| 87 | GRK5 | 0.76881287 |
| 88 | TNIK | 0.76636954 |
| 89 | WEE1 | 0.72453367 |
| 90 | STK3 | 0.72432087 |
| 91 | BUB1 | 0.72130410 |
| 92 | TYRO3 | 0.70686856 |
| 93 | INSRR | 0.69661858 |
| 94 | DAPK2 | 0.67946074 |
| 95 | PRPF4B | 0.67169986 |
| 96 | MKNK1 | 0.66998531 |
| 97 | CSNK2A2 | 0.65749360 |
| 98 | BMPR1B | 0.64571929 |
| 99 | CSNK1D | 0.63963481 |
| 100 | PIM1 | 0.63734911 |
| 101 | TSSK6 | 0.63638468 |
| 102 | WNK4 | 0.63587462 |
| 103 | PRKAA1 | 0.63433007 |
| 104 | PRKCD | 0.63048672 |
| 105 | VRK1 | 0.61879439 |
| 106 | EIF2AK2 | 0.61644688 |
| 107 | AKT2 | 0.60768810 |
| 108 | CSNK1E | 0.60177691 |
| 109 | STK38 | 0.57796077 |
| 110 | TAOK2 | 0.56431765 |
| 111 | CDK3 | 0.55763644 |
| 112 | PRKACA | 0.54693190 |
| 113 | RPS6KB2 | 0.52306032 |
| 114 | SIK3 | 0.51286575 |
| 115 | DDR2 | 0.51029665 |
| 116 | ERBB4 | 0.50148456 |
| 117 | MAP3K8 | 0.49839498 |
| 118 | GRK1 | 0.49604393 |
| 119 | KIT | 0.48598480 |
| 120 | AURKB | 0.48342327 |
| 121 | MAPK11 | 0.48141362 |
| 122 | PLK1 | 0.47541598 |
| 123 | CDK8 | 0.46917899 |
| 124 | TIE1 | 0.46909663 |
| 125 | HCK | 0.45768896 |
| 126 | MAP3K7 | 0.42315843 |
| 127 | LATS1 | 0.42253588 |
| 128 | PDK1 | 0.41555258 |
| 129 | ADRBK2 | 0.40652698 |
| 130 | PLK2 | 0.39993484 |
| 131 | LRRK2 | 0.38689720 |
| 132 | TGFBR1 | 0.38582339 |
| 133 | PINK1 | 0.38425522 |
| 134 | NEK6 | 0.36791005 |
| 135 | DYRK2 | 0.36638266 |
| 136 | PDGFRA | 0.36027048 |
| 137 | BRSK1 | 0.35980875 |
| 138 | CAMK4 | 0.35968421 |
| 139 | MAP2K1 | 0.35589290 |
| 140 | EGFR | 0.35120014 |
| 141 | RPS6KA5 | 0.34067483 |
| 142 | DYRK1A | 0.33833392 |
| 143 | KDR | 0.32966738 |
| 144 | SRC | 0.32817379 |
| 145 | RAF1 | 0.32706832 |
| 146 | PRKCE | 0.32078162 |
| 147 | IGF1R | 0.31996099 |
| 148 | MATK | 0.31919758 |
| 149 | MAP3K12 | 0.31213731 |
| 150 | PRKCB | 0.30925027 |
| 151 | FER | 0.30872135 |
| 152 | PRKDC | 0.30662434 |
| 153 | PRKCZ | 0.30247662 |
| 154 | PKN2 | 0.30242795 |
| 155 | CAMK1G | 0.29655831 |
| 156 | STK11 | 0.29610873 |
| 157 | CDK1 | 0.28268411 |
| 158 | ATR | 0.27500036 |
| 159 | MAP3K10 | 0.27294307 |
| 160 | OXSR1 | 0.26938154 |
| 161 | ARAF | 0.26927367 |
| 162 | CSNK1A1 | 0.26715753 |
| 163 | MET | 0.26304355 |
| 164 | INSR | 0.24685200 |
| 165 | MAPKAPK2 | 0.24241073 |
| 166 | PRKCA | 0.24061585 |
| 167 | MAPK8 | 0.22006216 |
| 168 | ZAP70 | 0.21686738 |
| 169 | SIK1 | 0.21166611 |
| 170 | PAK2 | 0.20325711 |
| 171 | EIF2AK3 | 0.20075899 |
| 172 | PRKG2 | 0.17914344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.78867678 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.06085660 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 3.72149329 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.93975507 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92687316 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.90632722 |
| 7 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.65561559 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.59680711 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.58162160 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.49794432 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.41593923 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25972537 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19286334 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17199748 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.09314413 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00925567 |
| 17 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.97839765 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.94583418 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.87576404 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82013541 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.79158314 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77797265 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.69131827 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.58855367 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58168456 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.52361513 |
| 27 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.47996742 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.47885046 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43515772 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36984971 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35937115 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30874814 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29815729 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25678872 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24832053 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23256511 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21891903 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21204614 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.20934029 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20421726 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13937061 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09682248 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07701178 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.06562083 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03731470 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03290027 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98869360 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.98684596 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96160021 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94453572 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88770103 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85861232 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.83282836 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80920552 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78426976 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.75237946 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74932493 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69505822 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68102828 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65914123 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64391191 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63370774 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62298564 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62064992 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61721775 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61277887 |
| 67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60529673 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.60408777 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58634207 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58553004 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57294821 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.56864617 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56721272 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56000139 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54656438 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53922841 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.53428052 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53294876 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52824393 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.52740716 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51786198 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51129512 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48420978 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48357609 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.48093732 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46759592 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46297004 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45046454 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42604309 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41953285 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41865231 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41014616 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39932874 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39858532 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39106396 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38785583 |
| 97 | Tuberculosis_Homo sapiens_hsa05152 | 0.36138925 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.35122239 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35112663 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33815674 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30549060 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30323789 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28707948 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28369750 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.28203609 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27298148 |
| 107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25612979 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25151097 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25129031 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.24514126 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23805714 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23731265 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22884377 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22070632 |
| 115 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.21471543 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.20860282 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20760009 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20502400 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | 0.20466852 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19757924 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.19129635 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.17465087 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17399855 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | 0.17139114 |
| 125 | Ribosome_Homo sapiens_hsa03010 | 0.15767546 |
| 126 | Measles_Homo sapiens_hsa05162 | 0.14959679 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12733677 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12480476 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.11481626 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09807122 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.09484152 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.08205356 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05138738 |
| 134 | DNA replication_Homo sapiens_hsa03030 | 0.05047516 |
| 135 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04032362 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03646718 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02932232 |
| 138 | Mismatch repair_Homo sapiens_hsa03430 | 0.02416216 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.02067064 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02023942 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | -0.1097713 |
| 142 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0980958 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0821835 |
| 144 | Nucleotide excision repair_Homo sapiens_hsa03420 | -0.0820140 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0793925 |
| 146 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0745829 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0542255 |
| 148 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0461742 |
| 149 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0241096 |
| 150 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0024625 |

